Association of three polymorphisms in ARID5B, IKZF1and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population

Gene

Volumn 524, Issue 2, 2013, Pages 203-207

  Wang, Yaping ^a   Chen, Jing ^b   Li, Jie ^c   Deng, Jianping ^a   Rui, Yaoyao ^a   Lu, Qin ^a   Wang, Meilin ^d   Tong, Na ^d   Zhang, Zhengdong ^d   Fang, Yongjun ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI CHILDREN S MEDICAL CENTER   (China)

^c CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ARID5B; Childhood acute lymphoblastic leukemia; Polymorphisms; Susceptibility

Indexed keywords

PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

ADOLESCENT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CCAAT-ENHANCER-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; CHINA; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HETEROZYGOTE; HUMANS; IKAROS TRANSCRIPTION FACTOR; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 84878631939     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.028     Document Type: Article

References (32)

1. Akagi T., et al. In vivo deficiency of both C/EBPbeta and C/EBPepsilon results in highly defective myeloid differentiation and lack of cytokine response. PLoS One 2010, 5:e15419.
2. Akasaka T., et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007, 109:3451-3461.
3. Belson M., Kingsley B., Holmes A. Risk factors for acute leukemia in children: a review. Environ. Health Perspect. 2007, 115:138-145.
4. Borst L., et al. Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia. Br. J. Haematol. 2012, 157(4):476-482.
5. Bourquin J.P., et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3339-3344.
6. Chang L.W., Payton J.E., Yuan W., Ley T.J., Nagarajan R., Stormo G.D. Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol. 2008, 9:R38.
7. Di Cristofaro J., Silvy M., Chiaroni J., Bailly P. Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use. J. Mol. Diagn. 2010, 12:453-460.
8. Eden T. Aetiology of childhood leukaemia. Cancer Treat. Rev. 2010, 36:286-297.
9. Georgopoulos K., et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994, 79:143-156.
10. Gombart A.F., Shiohara M., Kwok S.H., Agematsu K., Komiyama A., Koeffler H.P. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-epsilon. Blood 2001, 97:2561-2567.
11. Harker N., et al. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol. Cell 2002, 10:1403-1415.
12. Healy J., Richer C., Bourgey M., Kritikou E.A., Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 2010, 95:1608-1611.
13. Howard S.C., et al. Childhood cancer epidemiology in low-income countries. Cancer 2008, 112:461-472.
14. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat. Rev. 2010, 36:277-285.
15. Kuiper R.P., et al. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 2010, 24:1258-1264.
16. Lahoud M.H., et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res. 2001, 11:1327-1334.
17. Lekstrom-Himes J.A., Dorman S.E., Kopar P., Holland S.M., Gallin J.I. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J. Exp. Med. 1999, 189:1847-1852.
18. Lou C., et al. A SNaPshot assay for genotyping 44 individual identification single nucleotide polymorphisms. Electrophoresis 2011, 32:368-378.
19. Milne E., et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am. J. Epidemiol. 2012, 175:43-53.
20. Mullighan C.G., et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008, 453:110-114.
21. Onciu M. Acute lymphoblastic leukemia. Hematol. Oncol. Clin. North Am. 2009, 23:655-674.
22. Papaemmanuil E., et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet. 2009, 41:1006-1010.
23. Patsialou A., Wilsker D., Moran E. DNA-binding properties of ARID family proteins. Nucleic Acids Res. 2005, 33:66-80.
24. Prasad R.B., et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010, 115:1765-1767.
25. Pui C.H., Carroll W.L., Meshinchi S., Arceci R.J. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J. Clin. Oncol. 2011, 29:551-565.
26. Trevino L.R., et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet. 2009, 41:1001-1005.
27. Waanders E., et al. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia 2011, 25:254-258.
28. Wilsker D., Patsialou A., Dallas P.B., Moran E. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ. 2002, 13:95-106.
29. Xu H., et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 2012, 30:751-757.
30. Yang J.J., et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 2009, 301:393-403.
31. Yang W., et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 2010, 24:894-896.
32. Yang Y.L., et al. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci. 2011, 102:1874-1881.